Charcot-Marie-Tooth neuropathy axonal type 2N (often written CMT2N) is a rare inherited nerve disease. It mainly damages the long nerves that control movement and feeling in the feet, legs, hands, and arms. In this type, the main problem is inside the nerve “wire” (the axon), not in the myelin “insulation” layer. Because of this damage, signals from the brain and spinal cord travel more weakly to the muscles and skin. Over time, this leads to slowly progressive weakness, muscle wasting, and numbness, especially in the lower legs and later in the hands.MalaCards+1
Charcot-Marie-Tooth neuropathy axonal type 2N (CMT2N) is a rare inherited nerve disease that mainly damages the long nerves in the legs and arms. It belongs to the “axonal” group of Charcot-Marie-Tooth diseases, which means the problem is mainly in the nerve fiber (axon), not the myelin coating. In CMT2N, a change (mutation) in the AARS1 gene on chromosome 16 affects an enzyme called alanyl-tRNA synthetase, which is important for normal protein production in nerve cells.MalaCards+1
People with CMT2N usually develop slow-progressive weakness and wasting of muscles in the feet and lower legs first. Later, the weakness may spread to the hands and forearms. Sensation (feeling) in the feet is often reduced, ankle reflexes are usually absent, and balance may be poor. The disease is usually autosomal-dominant, meaning one changed copy of the gene is enough to cause disease. Progression is generally slow, and many people remain able to walk with support for many years.MalaCards+2Genetic & Rare Diseases Center+2
CMT2N happens because of a harmful change (mutation) in a gene called AARS (also called AARS1) on chromosome 16. This gene gives instructions for making an enzyme called alanyl-tRNA synthetase. The enzyme helps the cell build proteins correctly. When the enzyme does not work normally, nerve cells cannot keep their long axons healthy, so the axons slowly degenerate. Because nerves to the feet and hands are longest, they are affected first.disease-ontology.org+1
CMT2N is usually inherited in an autosomal dominant way. This means one changed copy of the AARS gene is enough to cause the disease. A person with the mutation has a 50% chance of passing it to each child, whether the child is a boy or a girl. The condition is lifelong and often mild to moderate, with slow worsening over many years.disease-ontology.org+1
Other names
Doctors and scientists may use several different names for the same condition. These names can appear in medical reports or genetics labs:disease-ontology.org+1
Charcot-Marie-Tooth disease axonal type 2N
Charcot-Marie-Tooth neuropathy axonal type 2N
CMT2N
Autosomal dominant axonal Charcot-Marie-Tooth disease type 2N
Autosomal dominant Charcot-Marie-Tooth disease type 2N
All of these names describe the same disease, related to a mutation in the AARS gene and causing an axonal form of CMT type 2.disease-ontology.org+1
Types
There is only one genetic subtype of CMT2N (AARS-related). But doctors may still talk about “types” in a clinical way, based on how and when it shows:MalaCards+1
Childhood-onset CMT2N – symptoms start in late childhood, such as frequent tripping, clumsy running, or early foot deformities.
Teenage-onset CMT2N – signs appear during the teenage years, often as difficulties in sports, running, or keeping balance in the dark.
Adult-onset CMT2N – symptoms first show in young or middle adulthood, usually as mild weakness or numbness in the feet.
Motor-predominant CMT2N – weakness and muscle wasting are the main problems; sensory loss is mild.
Sensorimotor CMT2N – both movement (motor) and feeling (sensory) nerves are clearly affected, with weakness plus numbness or reduced vibration sense.
Mild CMT2N – slow progression, with the person able to walk independently for many years.
Moderate CMT2N – more obvious foot deformities, walking difficulties, and sometimes hand weakness, but still not usually life-threatening.
These “types” are not separate genetic diseases; they simply describe different clinical patterns in people who all have AARS-related axonal CMT.Springer Link+1
Causes
Heterozygous mutation in the AARS gene
The main direct cause of CMT2N is a harmful change in one copy of the AARS gene. This gene codes for alanyl-tRNA synthetase, an enzyme needed for normal protein building. A single mutated copy (heterozygous state) is enough to disturb nerve function and cause axonal damage.disease-ontology.org+1Autosomal dominant inheritance from an affected parent
Many people with CMT2N inherit the mutation from a parent who also has CMT symptoms. Because the pattern is autosomal dominant, each child of an affected parent has a 1 in 2 chance of receiving the mutation and developing the disease.disease-ontology.org+1New (de novo) AARS mutation
In some families, CMT2N appears for the first time in one person. In these cases, the mutation may have occurred “de novo,” meaning it arose in the egg, sperm, or very early embryo. The parents may be unaffected, but the new mutation can be passed on to the next generation.American Academy of Neurology+1Missense change in the enzyme’s important region
Most AARS mutations in CMT2N are “missense” changes, where a single DNA letter change causes one amino acid in the enzyme to be replaced by another. When this happens in a key functional region, the enzyme can no longer work properly, especially in long nerve cells.PMC+1Impaired tRNA charging and protein synthesis
The main job of alanyl-tRNA synthetase is to attach the amino acid alanine to its tRNA, a vital step in protein production. When this function is disturbed, proteins in nerve cells are built incorrectly or too slowly. Long axons are very sensitive to such defects, and they begin to degenerate.PMC+1Length-dependent axonal degeneration
Because the longest nerves are most vulnerable, damage begins in the distal (far) parts of the axons that reach the feet and toes. This “length-dependent” process is a key cause of the early foot weakness and sensory loss seen in CMT2N.Europe PMC+1Disturbed axonal transport
Nerve cells must move nutrients, proteins, and small sacs (vesicles) along the axon. Mutant AARS may interfere with these transport systems. Over time, the axon cannot receive enough support and slowly withers, causing weakness and numbness.JBC+1Mitochondrial and energy stress in neurons
Axons need a lot of energy to maintain their long structure. Some studies suggest that aaRS mutations, including AARS, can cause cellular stress that affects mitochondria, the cell’s “power plants.” Less energy makes nerve fibers more likely to degenerate.PMC+1Chronic peripheral nerve injury without strong repair
In CMT2N, small amounts of damage happen slowly over years. The body tries to repair the axons, but because the root cause (the gene mutation) is always present, repair is never complete. This ongoing low-grade injury causes gradual progression of symptoms.Europe PMC+1Family clustering and shared genetic background
CMT2N often runs in families, and sometimes more than one mutation or genetic factor may influence severity. A shared genetic background can modify how strongly the AARS mutation affects different family members.balkanmedicaljournal.org+1Possible modifier genes in other nerve proteins
Other genes related to axonal health, such as those involved in cytoskeleton or myelin support, may modify disease expression. These are not primary causes, but they can worsen or soften the effect of the AARS mutation.Springer Link+1Cellular protein quality-control overload
Misfolded proteins due to faulty AARS may overload the cell’s quality-control systems (like the proteasome and autophagy). When these systems are overwhelmed, damaged proteins accumulate and further injure the axon.JBC+1Axonal vulnerability of motor neurons
Motor neurons that control the peroneal muscles (on the outer side of the lower leg) are especially vulnerable in CMT. This explains why weakness in ankle and toe lifting is often the first sign in CMT2N.MalaCards+1Axonal vulnerability of sensory neurons
Sensory fibers that carry vibration and position sense are also long and fragile. Damage to these axons causes numbness, tingling, and poor balance, especially in the dark or with eyes closed.Europe PMC+1Slow progression due to partial enzyme function
Many AARS mutations do not completely destroy the enzyme’s activity; they just reduce it. Because some function remains, the disease is usually slowly progressive rather than very rapid, but this partial loss still counts as an important cause of gradually worsening neuropathy.PMC+1No clear environmental trigger needed
Unlike some acquired neuropathies, CMT2N usually does not need toxins, diabetes, or infections to start. The gene mutation itself is enough to cause disease, even in an otherwise healthy person.Europe PMC+1Possible worsening with additional nerve stressors
Although the mutation is the main cause, other nerve stressors like uncontrolled diabetes, alcohol abuse, or certain neurotoxic drugs may worsen symptoms. These factors are not causes of CMT2N but can add extra harm to already fragile nerves.ARUP Consult+1Early developmental changes in peripheral nerves
In some people, abnormal nerve development begins before birth or in early childhood. Subtle wiring differences in the peripheral nervous system may make axons more likely to degenerate later.Europe PMC+1Genetic anticipation is not typical but variability exists
CMT2N does not usually show classic “anticipation,” but later generations may seem worse because of better recognition or other modifying factors. This variation may give the impression that the disease is becoming more severe in the family.balkanmedicaljournal.org+1Limited natural nerve regeneration
Human peripheral nerves can regenerate to some extent, but this ability is limited, especially in long axons and with a constant genetic defect. This limited repair capacity is another reason why axonal damage caused by AARS mutation leads to chronic, slowly worsening neuropathy.Europe PMC+1
Symptoms
Progressive weakness in feet and ankles
The most common early symptom is weakness in the muscles that lift the foot and toes. People may notice they trip more often, have trouble running, or cannot stand on their heels. This happens because the long motor nerves to these muscles are damaged first.MalaCards+1Muscle wasting in the lower legs
Over time, the muscles in the lower legs, especially around the shins and calves, become thinner. The legs may look like an “inverted champagne bottle,” with thin lower legs and relatively normal thighs, showing long-term nerve and muscle loss.MalaCards+1Foot deformities (high arches or hammertoes)
As muscles weaken unevenly, the balance between muscles and tendons changes. This can cause high foot arches (pes cavus), curled toes (hammertoes), or flat feet. These deformities can make walking painful and increase risk of ankle sprains.CMT Research Foundation+1Numbness or reduced feeling in the feet
Sensory nerves are also affected. People often feel numbness, tingling, or “pins and needles” in the toes and feet. They may not feel small injuries or temperature changes well, which can increase the risk of unnoticed wounds.MalaCards+1Loss of vibration and position sense
Vibration sense (feeling tuning forks) and position sense (knowing where the foot is without looking) become weaker. This makes it harder to walk on uneven ground and to stay balanced, especially in the dark or with eyes closed.Europe PMC+1Absent or reduced ankle reflexes
When the doctor taps the Achilles tendon with a hammer, the normal ankle jerk reflex may be weak or absent. Knee reflexes can also be reduced. This is a common exam sign that the peripheral nerves are not working properly.MalaCards+1Slowly progressive weakness in the hands
Later in the disease, the hands can also become weak. People may have trouble with fine tasks, such as buttoning shirts, writing, or opening small jars, because the small muscles in the hands are affected by axonal damage.MalaCards+1Hand muscle wasting
The muscles at the base of the thumb and between the fingers may become thinner. This wasting can make the hands appear bony and can reduce grip strength and dexterity over time.Europe PMC+1Gait problems and poor balance
Because of weakness and loss of sensation, the walking pattern changes. Some people develop a “steppage gait,” lifting the knees higher to avoid dragging the toes. Balance becomes more difficult, especially on uneven surfaces or when turning quickly.CMT Research Foundation+1Fatigue with walking or standing
Walking long distances or standing for a long time becomes tiring. The muscles must work harder to compensate for weak and uncoordinated movement. This leads to early fatigue and sometimes the need for rest or walking aids.CMT Research Foundation+1Neuropathic pain or discomfort
Some people develop burning, stabbing, or electric-like pain in the feet or legs. Others describe uncomfortable tingling or tightness. This “neuropathic” pain comes from damaged nerves sending abnormal signals.Europe PMC+1Cold or discolored feet
Because of nerve damage and reduced muscle activity, circulation in the feet may feel less active. Feet may feel cold or appear slightly bluish or pale, especially when sitting or standing still.Europe PMC+1Difficulty running and jumping
Activities that need quick ankle movement and power, like running, jumping, and climbing stairs, become hard early in the course of CMT2N. Many people stop sports that require fast footwork because of frequent tripping or ankle turning.CMT Research Foundation+1Mild scoliosis or posture changes (in some patients)
In some people with CMT, long-standing muscle imbalance may affect posture and the spine, leading to mild scoliosis or rounded shoulders. This is not specific to CMT2N, but it can occur as part of the overall neuromuscular picture.Wikipedia+1Emotional and social impact
Long-term physical limitations, pain, and visible deformities can cause emotional stress, anxiety, or low mood. People may avoid activities or feel self-conscious about their gait or leg shape. Psychological support is often an important part of care.ARUP Consult+1
Diagnostic tests
Physical examination tests
General neurological examination
The doctor checks muscle bulk, strength, tone, reflexes, and different types of sensation. In CMT2N, this exam often shows distal weakness, muscle wasting in the lower legs, reduced or absent ankle reflexes, and loss of vibration or position sense in the feet. This helps show that the problem is in the peripheral nerves.Europe PMC+1Gait and balance assessment
The clinician observes how the person walks, turns, and stands. A steppage gait, difficulty walking on heels or toes, and unsteady balance suggest a length-dependent neuropathy such as CMT2. Simple bedside tests, like walking in a straight line, can show subtle problems early.Europe PMC+1Foot and posture examination
The doctor examines the feet for high arches, hammertoes, or other deformities, and looks at leg shape for muscle wasting. Posture and spine alignment are also checked. These visible changes support a chronic neuropathy diagnosis and can guide orthotic or surgical planning.CMT Research Foundation+1Family examination (if relatives are present)
In some clinics, relatives may also be briefly examined. Finding similar but perhaps milder signs (such as high arches or reduced ankle reflexes) in a parent or sibling supports an inherited autosomal dominant pattern like that seen in CMT2N.balkanmedicaljournal.org+1
Manual and bedside tests
Manual muscle testing (MRC grading)
The examiner tests strength in specific muscles by asking the person to push or pull against resistance. Grading muscles in ankle dorsiflexion, plantarflexion, toe extension, and hand grip helps document the pattern and severity of weakness typical of axonal CMT.Europe PMC+1Romberg test
The Romberg test checks balance with eyes closed. The person stands with feet together; if they sway or lose balance much more with eyes closed than open, this suggests loss of position sense from sensory nerve damage, which is common in CMT2N.Europe PMC+1Heel-toe walking test
The patient is asked to walk on heels, then on toes, and sometimes along a straight line placing heel to toe. Difficulty, especially with heel walking, can reveal distal weakness in the ankle dorsiflexors, a classic feature of CMT2.CMT Research Foundation+1Functional mobility tests (for example, timed up-and-go)
Simple timed tests, such as standing up from a chair, walking a short distance, turning, and sitting down, measure functional movement. Slower times or unsteady movement suggest significant weakness and balance problems, helping track disease progression over time.CMT Research Foundation+1
Laboratory and pathological tests
Basic blood tests to rule out other causes
Blood tests such as glucose, vitamin B12, thyroid function, and kidney and liver tests help exclude other causes of neuropathy, like diabetes or vitamin deficiency. Normal results make a hereditary neuropathy such as CMT2N more likely.ARUP Consult+1Serum creatine kinase (CK)
CK is a muscle-related enzyme. In CMT, CK is often normal or only slightly raised. This pattern suggests that the main problem is nerve damage, not primary muscle disease, and helps guide further tests toward neuropathy.Europe PMC+1Genetic testing panel for CMT genes including AARS
Modern genetic tests use a panel that checks many CMT-related genes at once, including AARS. Finding a pathogenic heterozygous AARS mutation in a person with compatible symptoms confirms the diagnosis of CMT2N and allows family counseling.disease-ontology.org+1Targeted AARS gene sequencing or whole-exome sequencing
If a panel is negative or unavailable, more detailed sequencing of AARS or whole-exome sequencing may be used. These tests search the coding regions of many genes and can identify rare or new AARS variants associated with CMT2N.American Academy of Neurology+1Nerve biopsy (rarely required now)
In selected cases, especially before genetic tests were widely available, a small piece of a sensory nerve (often the sural nerve) was taken for study. In axonal CMT, biopsy shows marked axonal loss with relative preservation of myelin. Today, biopsy is used less often because genetic testing is safer and more precise.Europe PMC+1
Electrodiagnostic tests
Nerve conduction studies (NCS)
NCS measure how fast and how strongly electrical signals travel along nerves. In CMT2N, conduction velocities are usually normal or only slightly slowed, but the response size (amplitude) is reduced, showing axonal loss. This pattern distinguishes axonal CMT2 from demyelinating CMT1.Europe PMC+1Electromyography (EMG)
EMG uses a fine needle electrode in muscles to record electrical activity. In CMT2N, EMG often shows signs of chronic denervation and re-innervation, such as large motor unit potentials. This confirms that muscles are weak because of nerve damage, not primary muscle disease.Europe PMC+1Somatosensory evoked potentials (SSEPs)
SSEPs measure the brain’s response after a peripheral nerve is stimulated. In length-dependent axonal neuropathies, these responses from the legs may be delayed or reduced. This helps document sensory pathway involvement, especially in research or complex cases.Europe PMC+1Autonomic function tests (where indicated)
In some neuropathies, tests of sweating, heart-rate response, or blood-pressure changes can show autonomic nerve involvement. CMT2N is mainly a motor and sensory neuropathy, but if symptoms suggest autonomic problems, these tests can help rule in or rule out broader nerve involvement.ARUP Consult+1
Imaging tests
X-rays of feet and spine
Simple X-rays can show high arches, hammertoes, joint misalignment, or scoliosis. They do not diagnose CMT2N by themselves, but they help surgeons and orthopedists plan braces, insoles, or surgery to correct deformities and improve walking.CMT Research Foundation+1MRI of the spine and brain (to exclude other causes)
MRI scans are often normal in CMT2N. They are mainly done to rule out other conditions, such as spinal cord disease or brain lesions, when symptoms are unusual. A normal MRI with clear peripheral nerve findings supports the diagnosis of a hereditary neuropathy.ARUP Consult+1Ultrasound or MRI neurography of peripheral nerves
In some centers, imaging of the peripheral nerves themselves is performed. In axonal CMT, nerves may appear normal or only mildly enlarged, unlike in some demyelinating forms. These images can support the idea that the main damage is within the axon, fitting with CMT2N.Charcot-Marie-Tooth Association+1
Non-pharmacological treatments
Below are supportive therapies commonly used in CMT and related axonal neuropathies. They are not specific cures for CMT2N but are widely recommended to preserve function, reduce pain, and improve quality of life. Always follow a neurologist’s and physiotherapist’s advice.Mayo Clinic+2Charcot-Marie-Tooth Association+2
Physical therapy and strengthening exercises
Regular physical therapy helps keep muscles as strong and flexible as possible. A therapist designs a gentle program of strengthening and range-of-motion exercises to slow contractures and stiffness in ankles, knees, and hips. In CMT, expert groups recommend early PT to maintain walking ability, joint alignment, and balance and to delay deformities.Mayo Clinic+1Stretching and contracture prevention
Daily calf, hamstring, and foot stretches help prevent the ankle from pointing down permanently (equinus) and reduce toe clawing. Stretching keeps tendons and soft tissues longer so joints can move more easily. Guidelines for CMT stress stretching and joint mobilization as core non-surgical management for cavovarus feet and tight Achilles tendons.ENMC+1Ankle-foot orthoses (AFOs)
Light braces that support the ankle and foot can reduce foot drop, improve walking pattern, and lower the risk of falls. They hold the foot in a more neutral position and help clear the toes during swing phase of walking. CMT foot-care documents show that custom AFOs are a key part of conservative treatment before surgery.Charcot-Marie-Tooth Association+1Custom insoles and shoes
Special insoles, extra-depth shoes, and rocker-bottom soles help distribute pressure and compensate for high arches (pes cavus) and claw toes. This reduces pain under the ball of the foot and improves stability. Orthopedic and neuromuscular guidelines for CMT recommend shoe modifications for early deformities and pain relief.Charcot-Marie-Tooth Disease+1Occupational therapy for hand function
Occupational therapists teach fine-motor exercises and suggest tools like built-up pens, zipper pulls, and adapted cutlery. This helps people with hand weakness or numbness manage daily tasks such as writing, buttoning, and cooking. CMT associations highlight OT as important for independence in advanced disease.Mayo Clinic+1Balance and gait training
Because distal weakness and sensory loss affect balance, targeted balance training (for example, standing on different surfaces, tandem walking) can reduce falls. Gait training teaches safer walking techniques and correct use of braces or walking aids. Gait analysis studies in CMT show typical changes that can be improved by therapy and orthoses.www.elsevier.com+1Assistive devices: canes, walkers, and wheelchairs
Some people need a cane or walker for uneven ground or long distances. In more advanced stages, a wheelchair may be used for community mobility while preserving energy. Proper device prescription reduces fall risk and protects joints from repeated stress.Mayo Clinic+1Aquatic (water-based) therapy
Exercise in warm water supports the body and lowers joint load. This allows safer strengthening and stretching even with significant weakness or foot deformity. Studies in neuromuscular conditions show that aquatic therapy can improve endurance and comfort when land exercise is difficult.PMC+1Pain psychology and cognitive-behavioural therapy (CBT)
Chronic neuropathic pain can cause fear, poor sleep, anxiety, and depression. CBT and other pain coping strategies help people reframe pain, manage stress, and stay active while using medicines more safely. Neuropathic-pain guidelines recommend psychological support as part of multidisciplinary care.ScienceDirect+2وزارة الصحة السعودية+2Transcutaneous electrical nerve stimulation (TENS)
TENS uses small electrical currents through skin pads to reduce pain signals. For some people with focal neuropathic pain, guidelines recommend TENS as an additional, non-drug option. It is usually supervised initially by a pain specialist or physiotherapist.ScienceDirect+1Weight management and gentle aerobic exercise
Keeping a healthy weight reduces stress on weak ankles and feet. Low-impact activities like cycling, swimming, or walking with support help heart health and mood while avoiding over-fatigue. Peripheral neuropathy guidance stresses exercise and weight control to protect function and lower cardiovascular risk.PMC+1Fatigue management and energy conservation
CMT2N can cause fatigue because weak muscles work harder. Occupational therapists teach pacing, task planning, and use of seats or rolling carts to reduce fatigue. Structured energy-conservation programs are recommended across neuromuscular disorders to maintain participation in school, work, and family life.PMC+1Fall-prevention training and home safety changes
Simple changes such as removing loose rugs, adding grab bars, and improving lighting can strongly reduce injuries. Therapists may assess the home and suggest railings, non-slip mats, or stair modifications. CMT foot-surgery consensus papers emphasize fall prevention as part of long-term management.ENMC+1Vocational rehabilitation and workplace adaptations
Some people need changes in job tasks, working hours, or workstation design. Vocational rehabilitation services can help patients with CMT2N stay employed by adjusting duties and providing adaptive equipment, such as ergonomic keyboards or footrests.Mayo Clinic+1Respiratory and sleep assessment (selected cases)
Most CMT2N patients do not have severe breathing problems, but scoliosis, obesity, or other conditions can affect sleep and respiration. Sleep studies and respiratory assessments may be needed if there is loud snoring, pauses in breathing, or morning headaches. Addressing sleep apnea improves energy and quality of life.Mayo Clinic+1Support groups and patient organizations
Joining CMT support networks gives emotional support, practical tips, and news about research and trials. Organizations such as CMTA and national neuromuscular groups provide education, webinars, and clinical-trial news for different CMT subtypes.PMC+2PMC+2Genetic counseling for patients and families
Because CMT2N is usually autosomal-dominant, family members may want to know their risk. Genetic counseling explains inheritance, genetic testing, family planning options, and the meaning of AARS1 variants. Many clinical-genetics resources list CMT2N panels and recommend counseling as part of care.MalaCards+1Foot-care and skin-care education
Loss of feeling in the feet makes injuries harder to notice. Daily inspection for blisters, cuts, and pressure marks plus good nail care help prevent ulcers. Peripheral-neuropathy and diabetes guidelines show that careful foot care lowers the risk of infections and serious complications.nhs.uk+1Orthopaedic follow-up for deformities
Regular review by a foot-and-ankle surgeon familiar with CMT allows early correction of cavovarus feet or claw toes before they become rigid. Expert consensus stresses early surgical planning when conservative measures fail, to maintain a plantigrade (flat on the floor) foot.PubMed+2ENMC+2Participation in research and natural-history studies
Enrolling in CMT registries and natural-history studies helps doctors understand how CMT2N progresses and supports future trial design. Large CMT natural-history projects are already running and guide the development of new therapies.PMC+2ClinicalTrials.gov+2
Drug treatments for symptoms
Important safety note: No medicine is currently approved to cure or slow CMT2N itself. The drugs below are used to treat neuropathic pain, mood, sleep, and associated symptoms in peripheral neuropathy and CMT more generally. All are prescription medicines. Dose and timing must always be set by a neurologist or pain specialist after checking age, kidney and liver function, other medicines, and pregnancy status.PMC+2ScienceDirect+2
Gabapentin
Gabapentin is an anticonvulsant widely used as a first-line treatment for neuropathic pain. Guidelines recommend it for painful peripheral neuropathies, with typical adult total daily doses between about 900–3600 mg in three divided doses, titrated slowly.paindata.org+1 It works by binding to calcium channels in nerve cells, reducing abnormal pain signals. Common side effects include dizziness, sleepiness, and weight gain.WikipediaPregabalin (Lyrica)
Pregabalin is related to gabapentin and is licensed by the FDA for neuropathic pain such as diabetic neuropathy and post-herpetic neuralgia. Typical adult starting doses for neuropathic pain are about 150 mg/day in two or three doses, which may be increased up to 300–600 mg/day if needed and tolerated, as in FDA labeling.Wikipedia+3FDA Access Data+3FDA Access Data+3 It decreases calcium-channel activity, lowering abnormal nerve firing. Side effects include dizziness, sleepiness, blurred vision, and swelling in the legs.Duloxetine (Cymbalta and generics)
Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) approved for diabetic peripheral neuropathic pain and chronic musculoskeletal pain. FDA prescribing information recommends 60 mg once daily as a typical dose for neuropathic pain, with some patients going up to 120 mg/day.Wikipedia+3FDA Access Data+3FDA Access Data+3 It boosts serotonin and norepinephrine in pain pathways. Side effects may include nausea, dry mouth, sweating, and increased blood pressure.Amitriptyline
Amitriptyline is a tricyclic antidepressant (TCA) commonly used off-label for neuropathic pain at low doses. Guidelines list it as a first- or second-line option, with typical adult doses starting at around 10–25 mg at night and increasing up to about 75 mg/day if needed.وزارة الصحة السعودية+2northernlincolnshireapc.nhs.uk+2 It blocks reuptake of serotonin and norepinephrine and modulates sodium channels. Side effects can include dry mouth, constipation, weight gain, and sleepiness.Nortriptyline
Nortriptyline is another TCA often preferred in older patients because it may have fewer side effects than amitriptyline. It is used in similar low-dose ranges for neuropathic pain and improves pain by similar mechanisms. Clinical guidance often groups it with amitriptyline as first-line TCA therapy for neuropathic pain.ScienceDirect+1Venlafaxine
Venlafaxine is an SNRI that can be used when duloxetine is not suitable. Neuropathic-pain reviews list venlafaxine as an alternative SNRI with evidence in painful neuropathies.ScienceDirect+1 It increases serotonin and norepinephrine and may also affect pain-modulating pathways. Side effects include nausea, sweating, and possible blood-pressure increases.Topical lidocaine 5% patch
A 5% lidocaine patch is approved for post-herpetic neuralgia but also used in other focal peripheral neuropathies. It is applied to painful skin areas (often up to 12 hours on and 12 hours off, up to three patches at a time in adults, per FDA label).paindata.org+2وزارة الصحة السعودية+2 It numbs the skin and reduces local nerve firing. Side effects are usually mild skin irritation.High-concentration capsaicin 8% patch
Capsaicin patches are used in specialist settings for focal neuropathic pain. They work by desensitizing pain fibers through TRPV1 receptor activation, which initially causes burning but later reduces pain. Guidelines recommend them as a second-line option.ScienceDirect+1Tramadol
Tramadol is a weak opioid with serotonin-norepinephrine reuptake effects and can be used short-term for breakthrough neuropathic pain when first-line agents are not enough. Neuropathic-pain guidance places tramadol as a second-line or rescue medicine, not for long-term routine use because of dependence and side-effect risks.paindata.org+1Strong opioids (for severe, refractory pain)
Morphine, oxycodone, or similar strong opioids may be used only under specialist supervision when all other treatments fail, and disability from pain is extreme. International guidelines rate strong opioids as third-line because of high risks of tolerance, dependence, and serious side effects like constipation and respiratory depression.paindata.org+2ScienceDirect+2Carbamazepine and oxcarbazepine
These sodium-channel blockers are used mainly for trigeminal neuralgia but may help certain neuropathic pain states. They stabilize hyper-excitable neurons by prolonging sodium-channel inactivation. Side effects can include dizziness, double vision, low sodium, and blood-count changes, so regular monitoring is needed.ScienceDirect+1Topiramate and lamotrigine (selected cases)
Some guidelines list topiramate or lamotrigine as possible options for neuropathic pain in specialist care when first-line drugs are ineffective. Evidence is weaker than for gabapentinoids or SNRIs, so these are usually later-line choices.ScienceDirect+1Botulinum toxin A (for focal neuropathic pain)
In specialized centers, botulinum toxin A injections can relieve focal neuropathic pain by reducing neurotransmitter release from nerve endings. Reviews include it as an option for highly localized pain that has not responded to usual medicines.ScienceDirect+1NSAIDs and simple analgesics (limited role)
Common painkillers like paracetamol (acetaminophen) or non-steroidal anti-inflammatory drugs (NSAIDs) often do not help much with pure neuropathic pain, but they may reduce background musculoskeletal pain from abnormal gait and foot deformities. Guidelines state that NSAIDs are not primary neuropathic-pain drugs but can be used for mixed pain.ScienceDirect+1Muscle-relaxing agents for cramps (for example, baclofen)
Some patients have painful muscle cramps or spasticity. Drugs like baclofen may help by acting on GABA receptors in the central nervous system to reduce muscle over-activity. These drugs require careful dosing to avoid too much weakness or sleepiness.Physiopedia+1Antidepressants for mood and coping (SSRIs, SNRIs)
Depression and anxiety are common in chronic neuropathic disease. SSRIs (such as sertraline) and SNRIs (such as duloxetine or venlafaxine) can improve mood and indirectly reduce pain impact. Guidelines for neuropathic pain stress the importance of treating co-existing mood disorders as part of comprehensive care.ScienceDirect+2Wikipedia+2Sleep medicines used cautiously
Severe pain can disturb sleep. Short courses of sedating medications may be used in some adults, but non-drug sleep strategies and low-dose amitriptyline (which helps both sleep and pain) are usually preferred. Long-term sedative or benzodiazepine use is discouraged because of dependence and falls.ScienceDirect+1Topical compounded creams (for example, lidocaine with other agents)
Some pain centers prepare compounded creams combining local anesthetics and other agents for localized neuropathic pain areas. Evidence is limited, but they can provide relief with fewer systemic side effects in selected patients.ScienceDirect+1Vitamin B12 replacement when deficient
If a person with CMT2N also has vitamin B12 deficiency, treating that deficiency is essential because B12 is needed for myelin and nerve health. Studies suggest B12 may help neuropathic pain by supporting remyelination and nerve repair.nhs.uk+3Cleveland Clinic+3PubMed+3Participation in clinical trials of new agents
New drugs, gene therapies, and neuroprotective compounds for CMT are under investigation. Patients with certain CMT subtypes may be able to join appropriate clinical trials run under strict safety rules, sometimes including axonal types. This offers access to cutting-edge therapy but is not guaranteed treatment.PMC+2Labiotech.eu+2
Dietary molecular supplements
These supplements do not cure CMT2N, but some have evidence in other peripheral neuropathies. Always discuss dose and safety with a doctor, especially in children, pregnancy, or kidney/liver disease.
Alpha-lipoic acid (ALA)
Alpha-lipoic acid is an antioxidant that has been studied in diabetic polyneuropathy. Randomized trials show that oral ALA (often 600–1800 mg/day in adults) can improve neuropathic symptoms and nerve conduction, probably by reducing oxidative stress and improving blood flow to nerves.Cureus+4PubMed+4ClinicalTrials.gov+4Acetyl-L-carnitine (ALC)
ALC is involved in mitochondrial energy production. Meta-analyses in peripheral neuropathic pain suggest moderate pain reduction and possible nerve-regeneration benefits when ALC is used at doses such as 500–1000 mg two or three times daily in adults.PMC+2PLOS+2Vitamin B12 (cobalamin)
Vitamin B12 is essential for myelin formation and DNA synthesis. Deficiency can itself cause neuropathy, and supplementation (oral tablets or injections) improves symptoms in deficiency states. A review suggests B12 may reduce neuropathic pain by promoting myelination and nerve regeneration.Cleveland Clinic+2PubMed+2B-complex vitamins (B1, B6, B9, B12)
Combination products including thiamine (B1), pyridoxine (B6), folate (B9), and B12 are widely used for neuropathy. Some recent studies of fixed-dose ALA plus B vitamins show symptom improvement in diabetic neuropathy.MedRxiv+1Omega-3 fatty acids (EPA and DHA)
Omega-3 fats from fish oil or algae may support nerve health by reducing inflammation and supporting myelin. Animal and human research suggests omega-3s help protect and rebuild myelin and support brain and nerve function.@dsm-firmenich+4PMC+4Frontiers+4Vitamin D
Vitamin D deficiency is common and may worsen muscle weakness and bone health. While not a direct treatment for CMT2N, correcting deficiency supports general neuromuscular function and fall-prevention strategies.nhs.uk+1Magnesium
Magnesium plays a role in nerve transmission and muscle relaxation. Adequate intake may help reduce cramps and improve sleep, though evidence for neuropathic pain is limited. Food sources (nuts, seeds, leafy greens) are usually preferred over high-dose supplements unless a deficiency is documented.Verywell Health+1Coenzyme Q10 (CoQ10)
CoQ10 is involved in mitochondrial energy production. Small studies in neuromuscular conditions suggest CoQ10 may help fatigue and muscle symptoms, though data in CMT are limited. It is usually taken orally with doses adjusted by a physician.Charcot-Marie-Tooth Disease+1Curcumin (from turmeric)
Curcumin has anti-inflammatory and antioxidant properties and has been studied in various chronic pain conditions. It may modulate inflammatory signaling pathways, but strong data in hereditary neuropathies are lacking. It should be used cautiously with other medicines that affect clotting.Frontiers+1Choline-rich nutrients
Choline is a building block for acetylcholine and cell membranes. Articles on brain development and health note that choline, omega-3s, magnesium, and B vitamins together support nerve and brain function.The Times of India+1
Regenerative and immunity booster drugs
Currently, there are no approved stem-cell or regenerative drugs specifically for CMT2N. Research in CMT and other neuropathies is exploring stem cells, gene therapy, and advanced biologics. These approaches should only be accessed within regulated clinical trials.MDPI+5PMC+5Institut Myologie+5
Instead of listing specific “stem cell drugs” and doses (which do not exist for routine CMT2N care), an SEO-friendly and safe summary for your article is:
Mesenchymal stem cell therapy is being studied in diabetic and other neuropathies to promote nerve regeneration and reduce inflammation, but remains experimental.
Gene therapy approaches in CMT aim to deliver a healthy gene copy or modulate harmful gene products; early trials exist for some CMT subtypes but not yet standard for CMT2N.
Advanced regenerative strategies (for example, MSC-derived exosomes, personalized antisense oligonucleotides) are in preclinical or very early clinical stages.
Immune-modulating biologics are mainly used in autoimmune neuropathies, not genetic CMT2N, and are not standard treatment here.
For an accurate and ethical medical site, it is best to describe these as research directions, not as routine “treatment lists with doses.”MDPI+5PMC+5Frontiers+5
Surgeries
Surgery in CMT2N focuses on correcting foot and ankle deformities, improving balance, and reducing pain when braces and therapy are no longer enough. It does not fix the genetic cause.Charcot-Marie-Tooth Association+3ENMC+3PubMed+3
Tendon transfer procedures
Tendons from stronger muscles (for example, tibialis posterior) are moved to help lift the foot and balance muscle forces in cavovarus deformity. This can improve foot drop and reduce progressive deformity. Studies in CMT show that tendon transfers correct muscle imbalance and improve gait when done at the right stage.PubMed+2www.elsevier.com+2Osteotomies (bone realignment surgery)
Surgeons may cut and reposition bones in the midfoot, hindfoot, or first metatarsal to flatten a high arch and correct heel varus. Research on cavus-foot surgery in CMT shows that combinations of osteotomies plus tendon procedures can restore a more plantigrade, pain-free foot.PubMed+2www.elsevier.com+2Soft-tissue releases and plantar fasciotomy
Tight ligaments and the plantar fascia (the strong band under the foot) can be partially released to improve flexibility and allow better correction of deformities. Consensus statements warn against isolated plantar fascia release but support releases as part of combined procedures.ENMC+2PubMed+2Joint fusion (arthrodesis) in severe deformity
In severe, rigid deformities, surgeons may fuse certain joints (for example, triple arthrodesis) to stabilize the foot and prevent painful motion. This is usually reserved for advanced cases or adults where other procedures are not enough.ENMC+2PubMed+2Toe-straightening procedures
Claw toes can be straightened with tendon balancing and small bone procedures to improve shoe fit and reduce pain. CMT foot-surgery series show that correcting toe deformities together with arch and heel deformities improves gait and quality of life.Charcot-Marie-Tooth Disease+1
Prevention and lifestyle strategies
CMT2N cannot be prevented because it is genetic, but you can reduce complications and disability:
Start physiotherapy and orthotics early to keep joints flexible and feet aligned.ENMC+1
Avoid smoking and heavy alcohol use, which can worsen neuropathy and balance.nhs.uk
Maintain a healthy weight to reduce stress on weak ankles and knees.PMC+1
Protect your feet with well-fitting shoes and daily checks for injuries.nhs.uk+1
Treat vitamin deficiencies, especially B12 and vitamin D, when present.Cleveland Clinic+2PubMed+2
Stay physically active with safe, low-impact exercise like swimming or cycling.PMC+1
Work with a multidisciplinary team (neurologist, physio, orthopedic surgeon, pain specialist) for coordinated care.ENMC+1
Manage pain early using guideline-recommended drugs and non-drug methods to prevent chronic suffering and inactivity.ScienceDirect+2وزارة الصحة السعودية+2
Use fall-prevention strategies and home modifications to avoid fractures and injuries.ENMC+1
Consider genetic counseling for family planning and to understand inheritance risks.MalaCards+1
When to see a doctor
You should see a doctor or neurologist promptly if you or a family member notice:
New or worsening foot drop, tripping, or frequent falls.MalaCards+1
New numbness or burning pain in the feet or hands.Charcot-Marie-Tooth Association+1
Rapid change in walking, balance, or ability to climb stairs.
Signs of foot deformity (very high arches, claw toes) that are getting worse.ENMC+1
Unintentional weight loss, severe fatigue, or other systemic symptoms, which may suggest a second problem besides CMT.
Difficulty breathing at night, loud snoring, or morning headaches.
Any side effects from medicines such as severe dizziness, mood changes, swelling, or allergic reactions.Wikipedia+5FDA Access Data+5FDA Access Data+5
Emergency care is needed for sudden severe weakness, loss of bladder or bowel control, chest pain, or trouble breathing.
What to eat and what to avoid
Eat a balanced, whole-food diet rich in vegetables, fruits, whole grains, lean proteins, nuts, and seeds to support general nerve and muscle health.The Times of India+1
Include omega-3-rich foods, such as fatty fish, flaxseeds, and walnuts, which may support myelin and reduce inflammation.DukeNUS+3Frontiers+3ScienceDirect+3
Ensure enough B-vitamin intake, especially B12 (meat, fish, eggs, fortified foods) and folate (leafy greens, legumes), to support nerve health.EatingWell+3Cleveland Clinic+3PubMed+3
Get magnesium and vitamin D from food (leafy greens, nuts, dairy, safe sunlight, fortified foods) to support muscles and bones.Verywell Health+2The Times of India+2
Limit ultra-processed foods, high-sugar snacks, and sugary drinks that can lead to weight gain and inflammation.Verywell Health+1
Avoid excess alcohol, which can damage nerves and worsen neuropathy.nhs.uk+1
Avoid smoking, as it reduces blood flow to nerves and slows healing.nhs.uk
Be cautious with “mega-dose” supplements or unregulated herbal products that promise nerve cures; many lack evidence and can interact with medicines.Frontiers+1
Stay well hydrated with water and limit very caffeinated or sugary drinks that may disturb sleep and worsen cramps.
Tailor diet to other conditions (for example, diabetes, kidney disease) with help from a dietitian so that overall health and neuropathy care are aligned.nhs.uk+1
Frequently asked questions (FAQs)
Is Charcot-Marie-Tooth neuropathy axonal type 2N curable?
No. CMT2N is a genetic disease caused by changes in the AARS1 gene, and there is no cure yet. Current treatment focuses on symptom control, physical therapy, braces, surgery for deformities, and lifestyle changes. Research into gene therapy and regenerative treatments is active but still experimental.MalaCards+2PMC+2Can medicines stop the disease from getting worse?
At the moment, no medicine has been proven to stop or reverse CMT2N. Neuropathic-pain medicines and physical treatments help with pain and function but do not change the underlying gene problem.PMC+2ScienceDirect+2Is CMT2N life-threatening?
CMT2N is usually slowly progressive and mainly affects peripheral nerves, not brain or heart directly. Most people have a normal life span but may have increasing disability over time. Complications like falls, fractures, and severe deformities can affect quality of life.MalaCards+2Genetic & Rare Diseases Center+2How is CMT2N diagnosed?
Doctors combine clinical examination, nerve conduction studies, and genetic testing. CMT2N is confirmed when a compatible clinical picture and axonal neuropathy are found along with a disease-causing mutation in AARS1.MalaCards+2NCBI+2What is the difference between CMT1 and CMT2?
CMT1 is mainly a demyelinating neuropathy (myelin damage) with very slow conduction velocities, while CMT2, including CMT2N, is an axonal neuropathy with primary damage to the nerve fiber and relatively less change in myelin. Symptoms overlap but electrophysiology and genetics differ.MalaCards+1Can children with CMT2N play sports?
Many children and teens with mild CMT2N can do low-impact sports with proper ankle support and medical advice. Swimming and cycling are usually safer than high-impact running or jumping sports, which may increase injury risk.PMC+1Will everyone with CMT2N eventually need a wheelchair?
Not always. CMT2N has variable severity, and some people remain ambulant with braces and surgery, while others may need a wheelchair for longer distances. Early treatment and regular follow-up can prolong walking ability.MalaCards+1Should family members be tested for CMT2N?
Because the condition is usually autosomal-dominant, first-degree relatives may wish to have genetic counseling and, if appropriate, testing. The decision is personal and should be guided by a genetics professional.MalaCards+1Are stem cell therapies available now for CMT2N?
Stem cell treatments for peripheral neuropathy and CMT are under study in animal models and early human trials, especially for diabetic neuropathy. They are not standard treatment and should only be considered in approved clinical-trial settings.Eur J Med Health Sci+5Mayo Clinic+5PMC+5What about gene therapy for CMT2N?
Gene therapy research in CMT is advancing, with early trials in some subtypes. Personalized and vector-based gene therapies are being explored, but they remain experimental and are not yet routine care for CMT2N.Labiotech.eu+4Institut Myologie+4Charcot-Marie-Tooth Association+4Can diet alone treat CMT2N?
No diet can reverse the genetic mutation. However, a healthy diet that avoids vitamin deficiencies, supports a healthy weight, and includes nerve-supporting nutrients like omega-3s and B vitamins can help overall health and may indirectly support nerve function and mobility.The Times of India+4Cleveland Clinic+4PubMed+4Why do some medicines for pain not work for everyone?
Neuropathic pain varies from person to person, and each drug has different mechanisms and side-effect profiles. Evidence shows that only a portion of patients get strong relief from any single drug, so guidelines recommend trying several first-line options and sometimes combining them.Wikipedia+4ScienceDirect+4Wikipedia+4Is it safe to combine medicines and supplements?
Some combinations are safe, but others can interact and increase side-effects or bleeding risk. People with CMT2N should always tell their doctors about all prescription drugs, over-the-counter medicines, and supplements before starting anything new.ScienceDirect+2Frontiers+2Can pregnancy worsen CMT2N?
In many women with CMT, pregnancy is tolerated, but symptoms like balance problems or pain can temporarily worsen due to weight gain and hormonal changes. Women with CMT2N who are planning pregnancy need pre-pregnancy counseling, careful medicine review, and close monitoring.Charcot-Marie-Tooth Association+1What is the best long-term strategy for CMT2N?
The best long-term strategy is a multidisciplinary, preventive approach: early physiotherapy and orthotics, careful pain management using guideline-based drugs, regular orthopedic review for deformities, healthy lifestyle and diet, genetic counseling, and consideration of clinical-trial participation when appropriate.AFM Téléthon+4ENMC+4PMC+4
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 22, 2025.
